[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes

About

Dr. Fathi focuses his research on the development and clinical translation of novel therapies for acute leukemias. He currently leads multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies. He has a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.

 

Location

Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA

newsletter icon

Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie
Bristol Myers Squibb

Follow Us

facebook instagram youtube